rxstat › Shortages › Carboplatin

Carboplatin shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Carboplatin is in a widespread shortage in Canada. 2 of 3 reported products are affected. Manufacturers have not committed to a recovery date.
Products affected
2 of 3
In shortage since
Oct 21, 2020
Reports on file
20
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
CARBOPLATIN INJECTION BP
10MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02320371 · since Jan 1, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · since Oct 21, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · since Mar 3, 2021, no end estimate · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02320371 · ended Feb 26, 2026 · Requirements related to complying with good manufacturing practices.
Avoided
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Aug 9, 2024 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Oct 4, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended May 16, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION
10MG · LIQUID · TEVA CANADA LIMITED
DIN 02125439 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Nov 15, 2022 · Delay in shipping of the drug.
Resolved
CARBOPLATIN INJECTION BP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 02126680 · ended Nov 1, 2021 · Delay in shipping of the drug.

Showing 12 of 20 reports. All reports are on file with Health Canada.

What's happening

Carboplatin is currently affected by 2 active shortage reports filed with Health Canada by ACCORD HEALTHCARE INC, TEVA CANADA LIMITED.

The reported causes are: requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Carboplatin is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XA).

Recent changes

Common questions

When will Carboplatin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Carboplatin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other antineoplastic agents)

Partial shortageAmsacrine1 of 1 reported products affectedPartial shortageArsenic Trioxide1 of 3 reported products affectedPartial shortageBortezomib3 of 7 reported products affected · est. return Aug 28, 2026Partial shortageEribulin1 of 1 reported products affected · est. return Dec 31, 2026Partial shortageErlotinib3 of 14 reported products affected · est. return Jun 30, 2027Partial shortageLurbinectedin1 of 1 reported products affected

All other antineoplastic agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.